Literature DB >> 7694588

Human S-antigen: presence of multiple immunogenic and immunopathogenic sites in the Lewis rat.

M D de Smet1, G Bitar, F G Roberge, I Gery, R B Nussenblatt.   

Abstract

To identify the immunogenic and immunopathogenic sites present in human S-Antigen (S-Ag), 40 overlapping peptides that span the whole length of the S-Ag molecule were synthesized and tested in the Lewis rat model of experimental autoimmune uveitis. The most pathogenic sequences were 180-200, 340-360 and 350-370. Ten peptide sequences were identified that induced visible inflammation in the eye. A total of 23 peptides gave an in-vitro proliferative response following immunization in animals. The ability to generate an immune response was not linked to the pathogenic capacity of the sequence. The most pathogenic sequence, 340-360, was only weakly proliferative. Peptide 180-200 and peptide 340-360 gave higher T-cell proliferative responses, but these were lower than the maximal proliferative response observed with non-pathogenic sequences. In animals immunized with whole S-Ag, the majority of the determinants did not elicit a proliferative response, indicating that in S-Ag, the majority of the immunogenic determinants are cryptic and are not presented by the APC located in the lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694588     DOI: 10.1006/jaut.1993.1048

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  18 in total

1.  Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy.

Authors:  F Boisgerault; I Khalil; V Tieng; F Connan; T Tabary; J H Cohen; J Choppin; D Charron; A Toubert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

2.  Rodent models of experimental autoimmune uveitis.

Authors:  Rajeev K Agarwal; Phyllis B Silver; Rachel R Caspi
Journal:  Methods Mol Biol       Date:  2012

Review 3.  Cytokines in posterior uveitis: an update.

Authors:  V K Singh; G Rai
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 4.  A look at autoimmunity and inflammation in the eye.

Authors:  Rachel R Caspi
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

5.  Spontaneous retinopathy in HLA-A29 transgenic mice.

Authors:  Y Szpak; J C Vieville; T Tabary; M C Naud; M Chopin; C Edelson; J H Cohen; J Dausset; Y de Kozak; M Pla
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 6.  Experimental autoimmune uveitis: molecular mimicry and oral tolerance.

Authors:  V K Singh; K Nagaraju
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

7.  Retinal S-antigen Th1 cell epitope mapping in patients with Behcet's disease.

Authors:  Changlin Zhao; Peizeng Yang; Hao He; Xiaomin Lin; Liping Du; Hongyan Zhou; Aize Kijlstra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-29       Impact factor: 3.117

8.  Immunological and pathological investigations in equine experimental uveitis.

Authors:  Galina P Simeonova; Svetozar Z Krastev; Radostin S Simeonov
Journal:  Vet Res Commun       Date:  2016-06-25       Impact factor: 2.459

9.  Rationally evolving MCP-1/CCL2 into a decoy protein with potent anti-inflammatory activity in vivo.

Authors:  Anna Maria Piccinini; Kerstin Knebl; Angelika Rek; Gerhild Wildner; Maria Diedrichs-Möhring; Andreas J Kungl
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

10.  Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis.

Authors:  Lixia Luo; Jin Yang; Yumin Oh; Matthew J Hartsock; Shiyu Xia; Yoo-Chun Kim; Zheng Ding; Tuo Meng; Charles G Eberhart; Laura M Ensign; Jennifer E Thorne; Walter J Stark; Elia J Duh; Qingguo Xu; Justin Hanes
Journal:  J Control Release       Date:  2019-01-17       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.